Delivery Order SPE2DR25D2006-SPE2DR26F55XQ
- Not listed
- The Defense Logistics Agency awarded a $6,809.55 firm fixed price delivery order to AmerisourceBergen Drug Corp for Adapalene 0.1% Cream in 45-gram quantities, with an ultimate completion date of September 11, 2025. The award, issued on September 10, 2025, carries no set-aside designation and represents a competitively awarded contract. Performance will occur at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order valued at $5,044.01 to AmerisourceBergen Drug Corp for Adapalene 0.1% cream on August 27, 2025, with an ultimate completion date of September 24, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Adapalene 0.1% Cream (45GM) with a ceiling value of $2,118.00 under a firm fixed price contract type. The award was issued on September 17, 2025, with an ultimate completion date of September 18, 2025. This non-set-aside contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a routine pharmaceutical procurement supporting...
- AmerisourceBergen Drug Corp was awarded a delivery order on August 12, 2025, for Adapalene 0.1% cream in a 1-ounce formulation under a firm fixed-price contract valued at $11,269.53. The award was made without a set-aside designation and carries an ultimate completion date of September 9, 2025. This delivery order is issued against AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency Troop Support Medical, designated SPE2DX, which is valued at...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $12,622.89 for Adapalene 0.1% cream (1S) on September 17, 2025, with an ultimate completion date of October 15, 2025. The contract is a firm fixed price delivery order with no set-aside designation, funded by the Defense Logistics Agency's Medical Supply Chain division. This award represents a competitive procurement action and is classified as a child contract, indicating it...
- The Defense Logistics Agency awarded a delivery order valued at $1,288.88 to AmerisourceBergen Drug Corp for Adapalene 0.1% Cream (45GM) on September 11, 2025, with an ultimate completion date of September 12, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a child order under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $3,870.15 firm fixed-price order is for the supply of Adapalene 0.1% cream, a topical acne medication. The contract has an ultimate completion date of September 20, 2024. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a...
- This $4,179.74 delivery order contract was awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical supplier, for the delivery of 45 gram tubes of Adapalene 0.1% cream. The delivery order is part of a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, which provides a comprehensive range of medical commodities to support military treatment programs and facilities worldwide. This...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,691.01, is for the delivery of Adapalene 0.1% Cream in 45 gram tubes. The contract is a Firm Fixed Price Delivery Order and has an ultimate completion date of October 29, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This is a delivery order issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The order is for 4,557,605,012 units of Adapalene 0.1% cream, 45 grams, at a total ceiling value of $19,220.60. The contract is a firm fixed price delivery order, with no set-aside designation. Amerisourcebergen Drug Corp is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government,...
- SPE2DR25D2006Indefinite Delivery Contract
- SPE2DR25D2006-SPE2DR26F55XQDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Adapalene 0.1% Cream (45 grams) with a ceiling value of $1,382.89. This was a competitively awarded, firm fixed-price delivery order with no set-aside designation, with an ultimate completion date of November 6, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving the federal government's medical procurement needs, particularly for military and veteran healthcare systems. This delivery order represents a task placed under AmerisourceBergen's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of medications and medical supplies to support military healthcare programs worldwide. AmerisourceBergen's federal contract portfolio demonstrates consistent capability to fulfill competitive procurement requirements across diverse pharmaceutical products and therapeutic domains for the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.4k | 11/5/25 |